中国医药导报
中國醫藥導報
중국의약도보
CHINA MEDICAL HERALD
2014年
27期
78-82
,共5页
健肝消脂颗粒%非酒精性脂肪性肝病%临床研究
健肝消脂顆粒%非酒精性脂肪性肝病%臨床研究
건간소지과립%비주정성지방성간병%림상연구
Jiangan Xiaozhi Granule%Nonalcoholic fat-ty liver disease%Clinical research
目的:观察健肝消脂颗粒治疗气滞血瘀型非酒精性脂肪性肝病(NAFLD)的临床效果。方法选择2011年12月~2013年3月云南省中医医院就诊患者,将80例气滞血瘀型NAFLD患者随机分为两组,治疗组口服健肝消脂颗粒(5 g/次,3次/d),对照组口服荷丹片(1.46 g/次,3次/d),疗程均为3个月,观察治疗前后中医证候、肝脾CT比值、肝脏B超、血脂、肝脏功能酶学指标的改变。结果健肝消脂颗粒治疗NAFLD总效果较好;治疗组在改善证候总有效率方面优于对照组,差异有统计学意义(P<0.05);治疗组在改善肝脏酶学总有效率方面优于对照组,差异有统计学意义(P<0.05);治疗组在改善血脂总有效率方面与对照组比较,差异无统计学意义(P>0.05);治疗组在改善腹部B超总有效率方面优于对照组,差异有统计学意义(P<0.05);治疗组在升高肝脾CT比值方面与对照组比较,差异无统计学意义(P>0.05)。结论健肝消脂颗粒改善NAFLD患者中医证候、NAFLD严重程度、肝脏功能酶学指标、血脂指标效果较好,对NAFLD有较好的临床疗效;在改善肝脏酶学、肝脏B超、临床症状方面优于荷丹片,在改善肝脾CT比值及血脂作用方面与荷丹片疗效相当。
目的:觀察健肝消脂顆粒治療氣滯血瘀型非酒精性脂肪性肝病(NAFLD)的臨床效果。方法選擇2011年12月~2013年3月雲南省中醫醫院就診患者,將80例氣滯血瘀型NAFLD患者隨機分為兩組,治療組口服健肝消脂顆粒(5 g/次,3次/d),對照組口服荷丹片(1.46 g/次,3次/d),療程均為3箇月,觀察治療前後中醫證候、肝脾CT比值、肝髒B超、血脂、肝髒功能酶學指標的改變。結果健肝消脂顆粒治療NAFLD總效果較好;治療組在改善證候總有效率方麵優于對照組,差異有統計學意義(P<0.05);治療組在改善肝髒酶學總有效率方麵優于對照組,差異有統計學意義(P<0.05);治療組在改善血脂總有效率方麵與對照組比較,差異無統計學意義(P>0.05);治療組在改善腹部B超總有效率方麵優于對照組,差異有統計學意義(P<0.05);治療組在升高肝脾CT比值方麵與對照組比較,差異無統計學意義(P>0.05)。結論健肝消脂顆粒改善NAFLD患者中醫證候、NAFLD嚴重程度、肝髒功能酶學指標、血脂指標效果較好,對NAFLD有較好的臨床療效;在改善肝髒酶學、肝髒B超、臨床癥狀方麵優于荷丹片,在改善肝脾CT比值及血脂作用方麵與荷丹片療效相噹。
목적:관찰건간소지과립치료기체혈어형비주정성지방성간병(NAFLD)적림상효과。방법선택2011년12월~2013년3월운남성중의의원취진환자,장80례기체혈어형NAFLD환자수궤분위량조,치료조구복건간소지과립(5 g/차,3차/d),대조조구복하단편(1.46 g/차,3차/d),료정균위3개월,관찰치료전후중의증후、간비CT비치、간장B초、혈지、간장공능매학지표적개변。결과건간소지과립치료NAFLD총효과교호;치료조재개선증후총유효솔방면우우대조조,차이유통계학의의(P<0.05);치료조재개선간장매학총유효솔방면우우대조조,차이유통계학의의(P<0.05);치료조재개선혈지총유효솔방면여대조조비교,차이무통계학의의(P>0.05);치료조재개선복부B초총유효솔방면우우대조조,차이유통계학의의(P<0.05);치료조재승고간비CT비치방면여대조조비교,차이무통계학의의(P>0.05)。결론건간소지과립개선NAFLD환자중의증후、NAFLD엄중정도、간장공능매학지표、혈지지표효과교호,대NAFLD유교호적림상료효;재개선간장매학、간장B초、림상증상방면우우하단편,재개선간비CT비치급혈지작용방면여하단편료효상당。
Objective To observe the clinical effect of Jiangan Xiaozhi Granule in the treatment of nonalcoholic fatty liver disease (NAFLD) of type of qi stagnancy and blood stasis. Methods Patients who took treatment in Yunnan Province Hospital of Traditional Chinese Medicine from December 2011 to March 2013 were chosen, of those 80 patients with NAFLD of type of qi stagnancy and blood stasis were randomly divided into two groups, the treatment group took Jiangan Xiaozhi Granule (once 5 g, three times per day) orally and the control group took Hedan Tablet (once 1.46 g, three times per day) orally. Both groups were treated for three months. The changes of traditional Chinese medicine (TCM) syndrome, the CT ratio of liver and spleen, liver B-type ultrasonic, liver enzyme, blood lipid and liver enzymology index before and after treatment were observed. Results Jiangan Xiaozhi Granule had good clinical effects on the treatment of NAFLD. On the total effective rate of improving TCM syndrome and liver enzymology, the treatment group was superior to the control group and the differences were statistically significant (P<0.05);on the total effective rate of improving blood lipid, the differences of the treatment group and the control group were not statistically significant (P > 0.05); on the total effective rate of improving TCM syndrome and abdominal B-type ultrasonic, the treatment group was higher than the control group, the differences were statistically significant (P<0.05); in increasing the CT ratio of liver and spleen, the differences of the treatment group and the control group were not statistically significant (P>0.05). Conclusion Jiangan Xiaozhi Granule plays good results in ameliorating TCM syndrome, NAFDL damage, liver enzymes and blood lipids indexes and has good clinical effects on NAFLD. Jiangan Xiaozhi Granule is superior to Hedan Tablet in improving liver enzymology and liver B-type ultrasonic, while it has relatively equal effects in improving CT ratio of liver and spleen and blood lipids compared to Hedan Tablet.